ISSN: 1859 - 2872
Predictive factors for triple-negative breast carcinoma
Main Article Content
Keywords
Abstract
Objective: To determine the clinicopathologic factors and Ki67 expression predicting triple-negative breast cancer (TNBC). Subject and method: A descriptive study on 169 patients with breast cancer at the 108 Military Central Hospital from October 2015 to September 2020. The status of estrogen receptor (ER), progesteron receptor (PR), human epidermal growth factor receptor 2 (HER2) and Ki67 expression were examined by immunochemistry. Result: The mean age of the patients was 53.8 ± 12.2 years. The rate of tumor size larger than 2cm was 54.4% (92/169). The percentage of cases with tumor grade 2 was highest at 64.5% (109/169). The rate of axillary lymph node metastasis was 37.9%. TNBC accounted for 16.6%. The statistically significant correlation was observed between TNBC and location, tumor size, histological grade and Ki67 ≥ 14%. Conclusion: Our study suggested that the right side, histological grade 3 and Ki67 ≥ 14% were independent predictive factor of TNBC.
Article Details
References
2. Azizun-Nisa, Bhurgri Y, Raza F, Kayani N (2008) Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer. Asian Pac J Cancer Prev 9(4): 553-556.
3. Costa R, Oliveira F, Araújo A, & Vieira SC (2021) Prognostic factors in triple-negative breast cancer: A retrospective cohort. Revista da Associacao Medica Brasileira (1992) 67(7): 950-957.
4. Dang Cong Thuan et al (2018) HER2 status and relationship with prognostic factors in invasive breast carcinoma. Journal of medicine and pharmacy, Hue university of medicine and Pharmacy 8(4): 13-22.
5. Elwan A, Abdelrahman et al (2021) Clinicopathological features and treatment challenges in triple negative breast cancer patients: A retrospective cohort study. Turk patoloji dergisi 37(2): 121–129.
6. Lakhani S, Ellis I, Schinitt S et al (2019) WHO classification of tumours of the breast. 5th ad, International Agency for Research on Cancer, Lyon.
7. Nguyen Van Chu (2016) Studying application of molecular classification in breast cancer by immunohistochemical method, Doctoral Thesis in Medicine, Hanoi Medical University.
8. Pajenga E, Rexha T, Çeliku S, Ugrinska A, Bejtja G. (2016) Hormonal receptor, human epidermal growth factor and its association with breast cancer tumor characteristics in Albania. Cent Eur J Public Health 24(3): 171-175.
9. Ta Van To (2004) Research on morphology, immunohistochemistry and their prognostic value in breast carcinoma. Doctoral thesis of Medicine, Hanoi Medical University.
10. Tran Thi Hoai, Le Hong Quang, Nguyen Ngoc Tu, Doan Thi Hong Nhat (2022) Treatment results of stage I-II triple-negative breast cancer in Nghe An Oncology Hospital. Vietnam Medical Journal 518: 321-325.
Article Sidebar
